Researchers pulled 30 Mycobacterium tuberculosis fragments from a secretome library, then used docking to shortlist 14, including pieces of Mpt64 and Mpt70. No lab validation yet.
Recap by typeshit. Full story at Bioengineer.org.
She describes MOTS-c as a messenger made by mitochondria that may help muscles handle sugar. The framing is hers and not an established health claim.
Medscape covers research tying GLP-1 drug use to lower alcohol consumption. Tap through for the study details and what researchers found.
In a small 2022 trial, whey beat leucine-boosted collagen for muscle growth, while evidence that collagen prevents sports injuries is still missing.
The orexin agonist, FDA approved in August, is being studied for ADHD and Parkinson's fatigue. Takeda's R&D head compares its reach to GLP-1 drugs, though data is early.
A retrospective study in Cureus looks back at how well once-weekly semaglutide worked, and how safe it was, for teenagers with obesity.
The open-source tool pairs immunopeptidomics and transcriptomics with a deep learning model of peptide and T-cell receptor binding. Candidates are predictions, not tested in patients.
Loading…